ACQUIRED CORNEAL DYSTROPHY

ACQUIRED CORNEAL DYSTROPHY was reported 38 times

ACQUIRED CORNEAL DYSTROPHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antiseptic [EPC] 1 0.0002
1 Angiotensin Converting Enzyme Inhibitor [EPC] 11 0.0001
2 Aminosalicylate [EPC] 5 0.0000
3 Selective T Cell Costimulation Modulator [EPC] 5 0.0000
4 Interleukin-6 Receptor Antagonist [EPC] 4 0.0000
5 beta3-Adrenergic Agonist [EPC] 1 0.0000
6 Macrolide Antimicrobial [EPC] 1 0.0000
7 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
8 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
9 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
10 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
11 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
12 Purine Antimetabolite [EPC] 1 0.0000
13 Antirheumatic Agent [EPC] 1 0.0000
14 Insulin Analog [EPC] 4 0.0000
15 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
16 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
17 alpha-Adrenergic Blocker [EPC] 1 0.0000
18 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
19 Vitamin D [EPC] 2 0.0000
20 Azole Antifungal [EPC] 1 0.0000
21 Janus Kinase Inhibitor [EPC] 1 0.0000
22 Vitamin B12 [EPC] 2 0.0000
23 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
24 Estrogen [EPC] 1 0.0000
25 Platelet Aggregation Inhibitor [EPC] 3 0.0000
26 Vitamin C [EPC] 2 0.0000
27 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
28 beta-Adrenergic Blocker [EPC] 1 0.0000
29 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
30 Corticosteroid [EPC] 4 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
32 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
33 Benzodiazepine [EPC] 2 0.0000
34 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
35 Thalidomide Analog [EPC] 1 0.0000